Clinical utility gene card for: poikiloderma with neutropenia
Clinical utility gene card for: poikiloderma with neutropenia
复制标题
临床实用基因卡:皮肤异色症伴中性粒细胞减少症
DOI:
10.1038/ejhg.2012.298
复制
发表时间:
2013
影响因子:
5.2
通讯作者:
Y. Sznajer
中科院分区:
文献类型:
--
作者:
L. Larizza;Gloria Negri;E. Colombo;L. Volpi;Y. Sznajer
So far, 19 different C16orf57 mutations have been detected in 37 PN patients subjected to molecular-genetic testing. Of these 37 patients, 31 (84%) carry homozygous mutations, whereas the other six are compound heterozygous. 3 All identified mutations lead to the generation of truncated and most likely non-functional C16orf57 protein. C16orf57 is a 30–50 exonuclease essential for the biogenesis of the splicing apparatus. 4, 5 Several classes of mutations have been identified, listed here in order of decreasing prevalence: nonsense mutations (c. 232C> T, c. 243G> A, c. 258T> A, c. 267T> A, c. 415C> T, c. 541C> T, c. 673C> T); small out-of-frame deletions (c. 176_177delG, c. 179delC, c. 489_492del4, c. 496delA, c. 531delA, c. 683_893þ 1del12); and splicing alterations, including substitutions at canonical splice junctions or at splice-site consensus sequences (c. 265þ 2T> G, c. 266À1G> A, c. 450À2A> G, c. 502A> G, c. 504À2A> C, c. 693þ 1G> T). 2, 3, 6–10 No missense mutations have yet been found; c. 502A> G can be categorised as a splicing alteration because it leads to the excision of the fourth exon from the mature C16orf57-001 transcript. 2